Company Overview
About Craniometrix
Craniometrix is a San Francisco-based digital health company providing virtual dementia care coordination — connecting dementia patients, family caregivers, and healthcare providers through a telemedicine platform that delivers cognitive assessment, care planning, caregiver education, and ongoing care management for Alzheimer's and related dementia conditions. Founded by CEO Nikhil Patel and backed by Y Combinator with $6-6.5 million raised from Y Combinator, Quiet Capital, and Defy.vc, Craniometrix generated $1.9 million in revenue in 2024 and partners with the Johns Hopkins MIND at Home program — a validated community-based dementia care model developed by Johns Hopkins University School of Medicine.
Business Model & Competitive Advantage
Craniometrix's care coordination platform addresses the fragmentation of dementia care support: most families managing a dementia diagnosis navigate neurologist appointments, primary care coordination, caregiver burnout, legal planning (power of attorney, advance directives), safety modifications (home monitoring, medication management), and community support resources without a guide — each element requires separate research and provider coordination. Craniometrix's platform provides a unified care navigator relationship that coordinates across these domains: digital cognitive assessments (Craniometrix administers validated cognitive screening tools remotely), care plan development, caregiver coaching on behavioral symptoms, and referrals to vetted local dementia support resources and clinical trials.
Competitive Landscape 2025–2026
In 2025, Craniometrix competes in the digital dementia care market with DementiaMap (care navigation platform), Dementia Care Specialists (trained care advisor model), and telehealth platforms (Teladoc TDOC, Brightside Health) expanding into geriatric and cognitive care for dementia family support services. The dementia care market is structurally underserved — 6.7 million Americans living with Alzheimer's in 2023 creates a massive caregiver support need that traditional healthcare systems provide inadequately. Johns Hopkins MIND at Home validation provides clinical credibility for Craniometrix's care model. Y Combinator backing connects Craniometrix with the digital health and elder care technology investor community. The 2025 strategy focuses on health plan partnerships (Medicare Advantage plans with CHRONIC Care Act chronic care management billing), employer benefit channels (employees managing parent dementia care), and growing the behavioral symptom management coaching that reduces caregiver burnout and emergency utilization.
Key Differentiators
Emerging Innovator
Craniometrix is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
S2
S2 is an AI-powered security platform focused on vulnerability discovery and attack surface management for enterprise security teams. The company's platform combines automated scanning, AI-powered ana
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Epic Systems
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Compare Craniometrix with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Craniometrix? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Craniometrix Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Craniometrix vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →